BRIDGENE BIOSCIENCES
BridGene Biosciences is a biotechnology company using cutting-edge chemoproteomic technology to discover and develop small molecules. It enables covalent small molecules to perform proteome-wide screening in live cells, which results in highly selective small molecules that drug traditionally undruggable targets.
BRIDGENE BIOSCIENCES
Social Links:
Industry:
Biotechnology Therapeutics
Founded:
2018-01-01
Address:
Sunnyvale, California, United States
Country:
United States
Website Url:
http://www.bridgenebio.com
Total Employee:
1+
Status:
Active
Contact:
.(408) 498-8127
Email Addresses:
[email protected]
Total Funding:
50.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Font Awesome Mobile Non Scaleable Content Nginx Amazon
Current Employees Featured
Founder
Investors List
Dyee Capital
Dyee Capital investment in Series B - BridGene Biosciences
Junson Capital
Junson Capital investment in Series B - BridGene Biosciences
Lapam Capital
Lapam Capital investment in Series B - BridGene Biosciences
Kaitai Capital
Kaitai Capital investment in Series A - BridGene Biosciences
Takeda Ventures
Takeda Ventures investment in Series A - BridGene Biosciences
WeDo Capital Management
WeDo Capital Management investment in Series A - BridGene Biosciences
Pangu Venture Capital
Pangu Venture Capital investment in Series A - BridGene Biosciences
Official Site Inspections
http://www.bridgenebio.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "BridGene Biosciences"
BridGene Biosciences - Crunchbase Company Profile
BridGene Biosciences is a biotechnology company using cutting-edge chemoproteomic technology to discover and develop small molecules. It enables covalent small molecules to perform proteome-wide screening in live cells, …See details»
BridGene Biosciences, Inc. | LinkedIn
Bridgenebio.com 49 2 Comments Like Comment Share BridGene Biosciences, Inc. 3,957 followers 3mo Report this post We are thrilled to announce today that the first patient has been dosed in BridGene ...See details»
BridGene Biosciences - Bridging Undruggable Targets and …
SUNNYVALE, Calif., March 30, 2021 /PRNewswire/ -- BridGene Biosciences, Inc., a biotechnology company using cutting-edge technology to discover and develop small …See details»
BridGene Biosciences Announces $38.5 Million Series B Financing …
Jul 27, 2022 As a global organization, Junson Capital has investment professionals located in ... For more information, visit https://www.bridgenebio.com. Contact. Tiberend Strategic Advisors, …See details»
Bridging Undruggable Targets and Precision Medicines - BridGene …
San Jose, CA, July 27, 2022 – BridGene Biosciences, Inc., a biotechnology company leveraging a proprietary chemoproteomic platform to discover and develop small-molecule drugs for high …See details»
BridGene Biosciences Announces Strategic Collaboration with …
Jan 3, 2024 BridGene Eligible to Receive More Than $700 Million in Potential Upfront and Milestone Payments. SAN JOSE, Calif., Jan. 3, 2024 /PRNewswire/ -- BridGene Biosciences, …See details»
Galapagos establishes strategic collaboration with BridGene …
Jan 3, 2024 Strategic collaboration and licensing agreement further strengthens Galapagos’ growing early-stage pipeline in oncology precision medicine; Collaboration leverages …See details»
BridGene Biosciences Announces $12 Million Series A ... - BioSpace
SUNNYVALE, Calif., May 5, 2021 /PRNewswire/ -- BridGene Biosciences, Inc. a biotechnology company using cutting-edge chemoproteomic technology to discover and develop small …See details»
BridGene Biosciences' IMTAC ™ Small Molecule Discovery Platform ...
SAN JOSE, Calif., Oct. 7, 2021 /PRNewswire/ -- BridGene Biosciences, Inc., a biotechnology company using a unique chemoproteomic technology to discover and develop small molecules …See details»
BridGene Biosciences - Bridging Undruggable Targets and …
We are seeking talented and motivated individuals to join our team. This is a fantastic opportunity to learn and use cutting-edge science to tackle unmet medical needs.See details»
BridGene Biosciences Announces Strategic Collaboration with …
Jan 3, 2024 BridGene Biosciences, Inc., a leader in the discovery of small molecule drugs for traditional "hard-to-drug" targets, announced today a strategic collaboration and licensing …See details»
BridGene Biosciences Announces Strategic Collaboration with
Jan 3, 2024 BridGene Eligible to Receive More Than $700 Million in Potential Upfront and Milestone Payments. SAN JOSE, Calif., Jan. 3, 2024 /PRNewswire/ -- BridGene Biosciences, …See details»
Galapagos establishes strategic collaboration with BridGene …
Jan 3, 2024 Strategic collaboration and licensing agreement further strengthens Galapagos’ growing early-stage pipeline in oncology precision medicineCollaboration leverages …See details»
Bridging Undruggable Targets and Precision Medicines - BridGene …
Mar 8, 2023 First drug candidate will target root causes of debilitating neurological disorders. SAN JOSE, Calif., March 8, 2023 -- BridGene Biosciences, Inc., a biotechnology company that …See details»
BridGene Biosciences, Inc. | Insights
Jan 10, 2024 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Bridging Undruggable Targets and Precision Medicines - BridGene …
San Jose, CA, Mar. 7, 2024 – BridGene Biosciences, Inc., a pioneer in the development of covalent small molecule drugs for traditional “hard-to-drug” targets, announced today that the …See details»
BridgeBio - Crunchbase Company Profile & Funding
BridgeBio is a biotechnology company that focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D. BridgeBio creates a bridge from …See details»
BridGene Biosciences - Bridging Undruggable Targets and …
San Jose, Calif., Oct. 9, 2024 —BridGene Biosciences, a leader in the discovery of small molecule drugs for traditionally "hard-to-drug" targets, today announced it will present three …See details»
BridGene Biosciences Announces Titles and Authors of Five …
SAN JOSE, Calif., Sept. 30, 2021 /PRNewswire/ -- BridGene Biosciences, Inc., a biotechnology company using a unique chemoproteomic technology to discover and develop small molecules …See details»